Cardiac fibrosis

NG Frangogiannis - Cardiovascular research, 2021 - academic.oup.com
Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of
extracellular matrix proteins, is a common pathophysiologic companion of many different …

Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association

SL Chow, AS Maisel, I Anand, B Bozkurt, RA De Boer… - Circulation, 2017 - Am Heart Assoc
Background and Purpose: Natriuretic peptides have led the way as a diagnostic and
prognostic tool for the diagnosis and management of heart failure (HF). More recent …

Heart failure and kidney dysfunction: epidemiology, mechanisms and management

JC Schefold, G Filippatos, G Hasenfuss… - Nature Reviews …, 2016 - nature.com
Heart failure (HF) is a major health-care problem and the prognosis of affected patients is
poor. HF often coexists with a number of comorbidities of which declining renal function is of …

Pathophysiology and therapeutic approaches to acute decompensated heart failure

JN Njoroge, JR Teerlink - Circulation research, 2021 - Am Heart Assoc
Acute decompensated heart failure (ADHF) is one of the leading admission diagnoses
worldwide, yet it is an entity with incompletely understood pathophysiology and limited …

Galectin-3: one molecule for an alphabet of diseases, from A to Z

S Sciacchitano, L Lavra, A Morgante, A Ulivieri… - International journal of …, 2018 - mdpi.com
Galectin-3 (Gal-3) regulates basic cellular functions such as cell–cell and cell–matrix
interactions, growth, proliferation, differentiation, and inflammation. It is not surprising …

Galectin-3 in cardiovascular diseases

V Blanda, UM Bracale, MD Di Taranto… - International journal of …, 2020 - mdpi.com
Galectin-3 (Gal-3) is a β-galactoside-binding protein belonging to the lectin family with
pleiotropic regulatory activities and several physiological cellular functions, such as cellular …

Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure …

RA de Boer, G De Keulenaer… - European journal of …, 2019 - Wiley Online Library
Fibrosis is a pivotal player in heart failure development and progression. Measurements of
(markers of) fibrosis in tissue and blood may help to diagnose and risk stratify patients with …

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?

M Sweeney, B Corden, SA Cook - EMBO molecular medicine, 2020 - embopress.org
Cardiac fibrosis is central to the pathology of heart failure, particularly heart failure with
preserved ejection fraction (HF p EF). Irrespective of the underlying profibrotic condition (eg …

Macrophages during the fibrotic process: M2 as friend and foe

TT Braga, JSH Agudelo, NOS Camara - Frontiers in immunology, 2015 - frontiersin.org
Macrophages play essential activities in homeostasis maintenance during different
organism's conditions. They may be polarized according to various stimuli, which …

[HTML][HTML] Galectin-3 activation and inhibition in heart failure and cardiovascular disease: an update

N Suthahar, WC Meijers, HHW Silljé, JE Ho, FT Liu… - Theranostics, 2018 - ncbi.nlm.nih.gov
Galectin-3 is a versatile protein orchestrating several physiological and pathophysiological
processes in the human body. In the last decade, considerable interest in galectin-3 has …